Background: Histologic tumor necrosis (TN) is a well-established independent prognostic indicator in patients treated surgically for clear cell renal cell carcinoma (ccRCC). However, the precise mechanisms by which TN alters disease progression remain unknown. The DEAD-box protein DDX41, a member of a large family of helicases, has been characterized as a pattern recognition receptor against an array of double-stranded (ds)DNA produced from bacteria, dsDNA viruses, and nearby cells that have released dsDNA fragments through necrosis. We hypothesized that DDX41 expression may be upregulated in ccRCC with TN, leading to worse prognosis.
Methods: Relationship between the presence of TN and DDX41 expression were examined using The Cancer Genome Atlas data sets or using ccRCC samples in our institution. Further, the molecular functions of DDX41 were investigated with human ccRCC cells.
Results: The presence of TN was significantly associated with the upregulation of mRNA and protein expression of DDX41 in the 2different patient cohorts with ccRCC. In addition, the mRNA and protein expression levels of DDX41 revealed a worse prognosis. In vitro analyses with ccRCC cells revealed that DDX41 expression promotes tumor-promoting activity. Furthermore, VHL loss, 1of the most common features in ccRCC, was shown to play an extremely important role in increasing the expression of the CXCL family in DDX41-expressing ccRCC, leading to the acquisition of a worse malignant phenotype.
Conclusions: DDX41 expression is associated with TN in ccRCC and leads to a worse prognosis in cooperation with VHL loss.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.urolonc.2022.07.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Biallelic germline DDX41 variants in a patient with bone dysplasia, ichthyosis, and dysmorphic features.
Hum Genet
December 2024
NIH Undiagnosed Diseases Program, Common Fund, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Article Synopsis
- * A patient with compound heterozygous DDX41 variants exhibited symptoms including bone dysplasia and ichthyosis, and analysis of their skin cells showed reduced DDX41 levels and disruption of immune gene activation.
- * Further studies revealed significant gene dysregulation and increased periostin mRNA in the patient’s cells, indicating that impaired DDX41 function and altered periostin expression likely contribute to the patient's complex disorder.
Cell cycle inhibitors activate the hypoxia-induced DDX41/STING pathway to mediate antitumor immune response in liver cancer.
JCI Insight
November 2024
Department of Pathology, School of Clinical Medicine, and.
Article Synopsis
- Cell cycle inhibitors like Paclitaxel and Palbociclib not only halt cancer cell division but also trigger the STING signaling pathway, enhancing their anti-cancer effects.
- These inhibitors lead to DNA damage and the activation of immune responses, particularly through the DDX41 and SASP factors, which promote immune cell infiltration into tumors.
- The study suggests that combining cell cycle inhibitors with immunotherapy could improve treatment outcomes, especially in certain types of cancer like hypoxic HCC, where STING signaling is more pronounced.
Acetylcytidine modification of DDX41 and ZNF746 by -acetyltransferase 10 contributes to chemoresistance of melanoma.
Front Oncol
August 2024
Department of Dermatology, The People's Hospital of Yuxi City, Kunming Medical University, Yuxi, Yunan, China.
Background: Rapidly developed chemoresistance to dacarbazine (DTIC) is a major obstacle in the clinical management of melanoma; however, the roles and mechanisms of epi-transcriptomic RNA modification in this process have not been investigated.
Method: DTIC-resistant (DR) melanoma cells were established for bulk RNA sequencing. The expressions of mRNAs were detected using qRT-PCR, and protein levels were determined using Western blotting and immunohistochemistry.
DDX41 haploinsufficiency causes inefficient hematopoiesis under stress and cooperates with p53 mutations to cause hematologic malignancy.
Leukemia
August 2024
Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Germline heterozygous mutations in DDX41 predispose individuals to hematologic malignancies in adulthood. Most of these DDX41 mutations result in a truncated protein, leading to loss of protein function. To investigate the impact of these mutations on hematopoiesis, we generated mice with hematopoietic-specific knockout of one Ddx41 allele.
View Article and Find Full Text PDFDiscovery and Characterization of the Gene in Atlantic Salmon: Evolutionary Implications, Structural Functions, and Innate Immune Responses to and Infections.
Int J Mol Sci
June 2024
ADL Diagnostic Chile, Sector la Vara, Puerto Montt 5480000, Chile.
The innate immune response in , mediated by pattern recognition receptors (PRRs), is crucial for defending against pathogens. This study examined DDX41 protein functions as a cytosolic/nuclear sensor for cyclic dinucleotides, RNA, and DNA from invasive intracellular bacteria. The investigation determined the existence, conservation, and functional expression of the gene in .
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!